Comparison
Company
Score
Quality
Valuation
Financial
Technical
Why is Theralase Technologies, Inc. ?
1
Flat results in Mar 25
- ROCE(HY) Lowest at -291.48%
- DEBTORS TURNOVER RATIO(HY) Lowest at 1.55%
- RAW MATERIAL COST(Y) Grown by 6,330% (YoY)
2
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of -35.42%, its profits have risen by 3%
3
Below par performance in long term as well as near term
- Along with generating -35.42% returns in the last 1 year, the stock has also underperformed S&P/TSX 60 in the last 3 years, 1 year and 3 months
How much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Theralase Technologies, Inc. for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Theralase Technologies, Inc.
-100.0%
-0.10
66.53%
S&P/TSX 60
19.1%
1.25
15.27%
Quality key factors
Factor
Value
Sales Growth (5y)
3.37%
EBIT Growth (5y)
7.98%
EBIT to Interest (avg)
-4.83
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.03
Sales to Capital Employed (avg)
0.57
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.05%
ROCE (avg)
0
ROE (avg)
0
Valuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
38.83
EV to EBIT
-11.43
EV to EBITDA
-12.17
EV to Capital Employed
37.91
EV to Sales
46.43
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-331.64%
ROE (Latest)
-335.23%
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
Technical Movement
6What is working for the Company
OPERATING CASH FLOW(Y)
Highest at CAD -2.59 MM
NET PROFIT(HY)
Higher at CAD -2.39 MM
-10What is not working for the Company
ROCE(HY)
Lowest at -291.48%
DEBTORS TURNOVER RATIO(HY)
Lowest at 1.55%
RAW MATERIAL COST(Y)
Grown by 6,330% (YoY
INVENTORY TURNOVER RATIO(HY)
Lowest at 1.21%
OPERATING PROFIT(Q)
Lowest at CAD -1.42 MM
PRE-TAX PROFIT(Q)
Lowest at CAD -1.47 MM
NET PROFIT(Q)
Lowest at CAD -1.47 MM
EPS(Q)
Lowest at CAD -0.01
Here's what is working for Theralase Technologies, Inc.
Operating Cash Flow
Highest at CAD -2.59 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (CAD MM)
Here's what is not working for Theralase Technologies, Inc.
Debtors Turnover Ratio
Lowest at 1.55% and Fallen
In each half year in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling Debtors has slowed
Debtors Turnover Ratio
Operating Profit
Lowest at CAD -1.42 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is negative
Operating Profit (CAD MM)
Pre-Tax Profit
Lowest at CAD -1.47 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is negative
Pre-Tax Profit (CAD MM)
Net Profit
Lowest at CAD -1.47 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is negative
Net Profit (CAD MM)
EPS
Lowest at CAD -0.01
in the last five periodsMOJO Watch
Declining profitability; company has created lower earnings for shareholders
EPS (CAD)
Inventory Turnover Ratio
Lowest at 1.21%
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling inventory has slowed
Inventory Turnover Ratio
Raw Material Cost
Grown by 6,330% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales






